Despite safety concerns, many young patients with implantable cardioverter-defibrillators (ICDs) participate in sports. We undertook a prospective, multinational registry to determine the incidence of serious adverse events because of sports participation. The primary end points were death or resuscitated arrest during sports or injury during sports because of arrhythmia or shock. Secondary end points included system malfunction and incidence of ventricular arrhythmias requiring multiple shocks for termination.
U
ntil recently, guidelines have recommended against all moderate and high-intensity sports for athletes with implantable cardioverter-defibrillators (ICDs) because the safety and efficacy of ICDs during competition was unknown, and there was concern for risk. [1] [2] [3] [4] [5] [6] [7] The classification of sports for athletes with heart disorders has been developed to allow for reasonably safe recommendations for this population and was based on peak static and dynamic components achieved during competition. 3, 4 At the 36th Bethesda Conference in 2005, it was recommended, based on expert opinion, that athletes of all ages with ICDs who have experienced no arrhythmias for 6 months may engage in class 1A competitive sports (eg, billiards, bowling, and golf) as the cardiovascular demands were considered low, there was little chance for high impact contact, and there was minimal risk for injury if syncope were to occur during play. 1 The postulated risks of patients with ICDs participating in competitive or higher intensity sports include potential failure of the ICD to defibrillate owing to metabolic, autonomic, or potentially ischemic changes during intense exercise, potential death or risk of harm owing to momentary loss of control from arrhythmia or ICD shock, or damage to the device or lead system. 1, 2, [5] [6] [7] [8] [9] [10] Growing evidence suggests that risks of sports participation for athletes with ICDs may be lower than hypothesized. Surveys from the Heart Rhythm Society and the Pediatric and Congenital Electrophysiology Society, 6, 7 as well as a small single-center registry, 10 suggest that a significant number of patients with ICDs participate in sports without adverse events. Thus, in 2006, the ICD Sports Registry was initiated. Reported in 2013 and 2017, 440 athletes with ICDs aged 10 to 60 years who participated in organized sports in spite of standing recommendations were 8, 9 prospectively followed for a median of 44 months. Although appropriate and inappropriate shocks occurred during sports, there were no deaths, resuscitated arrest, or arrhythmia-related injury during sports. That study concluded that many ICD athletes can participate in vigorous or competitive sports without injury or failure to terminate the arrhythmia, despite shocks. 8, 9 Data from the ICD Sports Registry are reassuring suggesting safe sports participation in patients with ICD. These data were difficult to apply to children and adolescents, and thus, the current post hoc analysis was performed to better understand this young population. These data will allow pediatric cardiologists to engage in more informed shared decisionmaking for children and adolescents with ICDs, and their families, as they weigh decisions about how and when to return to sports participation after ICD implantation.
METHODS
The data, analytic methods, and study materials will not be made available at this time to other researchers for purposes of reproducing the results or replicating the procedure as analyses are still ongoing.
Methods of the ICD Sports Registry have been reported in detail previously. 8 
Patients
Athletes with ICDs aged 10 to 60 years already participating in organized sports involving regular practice and regularly scheduled competition in sports that are typically classified as greater than category IA 3 were eligible to participate. The consent process emphasized that study participation did not mean endorsement of sports participation. Participants in potentially high-risk sports, defined as those in which a brief loss of control could result in injury (eg, skiing or surfing), were also enrolled. Those participants aged 10 to 21 years were included in this subanalysis.
This study was approved by the Yale Human Investigation Committee and by the institutional review boards of each participating site. All patients signed an informed consent. Information was also disseminated via mailings to physicians and via patient group internet sites and mailing lists and patients could enroll directly through the central site (Yale). For self-enrolled patients, consent and medical release forms were discussed by telephone, and signed copies were returned by facsimile/email. The sports registry included a total of 440 athletes (mean age, 40 years; range, 10-60 years), including 129 participants aged ≤21 years (median age, 17 years; range, 10-21 years), who form the population for this analysis. Patients were enrolled between 2006 and 2014; the database closed on January 2015.
WHAT IS KNOWN?
• Despite safety concerns, young patients with implantable cardioverter-defibrillators participate in sports.
• A prospective, multinational registry was designed to determine the incidence of serious adverse events because of sports.
• The registry studied end points including death or resuscitated arrest during sports or injury during sports because of arrhythmia/shock.
WHAT THE STUDY ADDS?
• Shocks related to competition and practice occur in college and high school athletes with implantable cardioverter-defibrillators.
• These shocks during sports were not associated with serious adverse sequelae. • Lead malfunction rates were similar to rates previously reported in unselected implantable cardioverter-defibrillator youth populations.
Study Design
Data were collected and entered into a secure Web-based database by the central site. Patients were contacted by telephone to obtain data on sports participation, and clinical information was obtained from medical records. Patients or their parents were instructed to contact the central site if they experienced an ICD shock and were queried about preceding activity and any sequelae. Preshock activity was categorized as competition/practice/post-competition or practice (within 2 hours), other physical activity (recreational activity or other exertion, such as running for a bus), or rest. Patients/parents were also contacted by phone every 6 months and were queried about shocks experienced and any changes in sports participation, health, ICD status, or injuries. Overall compliance with scheduled every 6-month interviews was 77%. If interviews were missed, information for the missed 6-month period was obtained in the next call 6 months later. Medical records were obtained from sites or treating physicians or facilities and were reviewed by study personnel for any shock, changes in health or ICD status (eg, lead replacement, death), or injuries received. Stored ICD electrograms and event detail data were reviewed for rhythm diagnosis and shock outcome by 2 electrophysiologists, as were clinical data on system malfunction. If the stored electrogram was not saved and could not be retrieved, and thus was unavailable to the study team, the diagnosis of the treating ICD physician was reported. Vital status was determined for patients lost to follow-up through contact with their treating physician and device company. The database was closed on January 31, 2015.
Primary End Points
The primary predetermined end point was a serious adverse event during or ≤2 hours after sports defined as (1) tachyarrhythmic death or externally resuscitated tachyarrhythmia caused by shock failure, incessant ventricular arrhythmia, or postshock pulseless electric activity or (2) severe injury, defined as requiring hospitalization resulting from shock or syncopal arrhythmia.
Secondary End Points
Secondary end points included (1) numbers of appropriate (for ventricular tachyarrhythmia) and inappropriate shock episodes (both defined as a device-counted episode); (2) multiple shocks within 1 appropriate shock episode (ie, failure of first maximum-energy shock or recurrent arrhythmia); (3) moderate injury (requiring emergency room visit) associated with a shock; (4) ICD lead/system damage, including definite lead malfunction defined as change in pacing function with documented noise on electrogram or visible lead abnormality or probable malfunction, change in pacing function only. Sitereported lead malfunctions for which no clinical data could be obtained were also classified as probable. All end points were reviewed periodically by the Data Safety Monitoring Board.
Statistical Analysis
Descriptive statistics were used to summarize patient characteristics, sports participation, and shock episodes. The binomial 95% CI for adverse events was estimated with the exact method. The Fisher exact test was performed to compare the frequency of multiple shocks across activity categories and to compare the incidence of sports-related shocks for demographic and clinical variables. The McNemar test was performed to compare in a pairwise fashion the fraction of people shocked during competition with those receiving shocks during other physical activity or at rest. For the primary end point and the secondary end points related to shocks, we assumed missing data was completely at random. For the secondary end point related to ICD lead malfunction/damage, we treated missing data as censored. To mitigate the effect of missing data as result of dropout, we report secondary end points, where appropriate, as the rate of shocks over time.
Survival analyses were performed for time to lead malfunction by the Kaplan-Meier method based on the date of lead implantation. All analyses were performed with SAS, version 9.2 (SAS Institute, Inc, Cary, NC). This subgroup analysis done for youth included all patients ≤21 years of age at the time of enrollment.
RESULTS
Among the 129 athletes ≤21 years old, 9% were 10 to 12 years of age, 26% were 13 to 15 years of age, 41% were 16 to 18 years of age, and 24% were 19 to 21 years of age. Demographic and clinical characteristics of this youth cohort are shown in Table 1 and Table A in the Data Supplement. Forty percent of patients were female; 92% were white. The most common diagnoses were long QT syndrome (n=49), hypertrophic cardiomyopathy (n=30), and congenital heart disease (n=15). Among the athletes with congenital heart disease, tetralogy of Fallot (n=5) and D-transposition of the great arteries (n=5) were the most common diagnoses and there were no athletes with univentricular hearts.
Seventy-three percent of the subgroup were prescribed β-blockers. The mean left ventricular ejection fraction in this cohort was 66% (interquartile range [IQR], 59-71). All defibrillators were transvenous. Median time since implantation was 18 months (IQR, 9-40 months) with 6 patients enrolled within 1 year of implantation. The lowest zone for treatment of arrhythmia was set at a median of 214 beats per minute (IQR, 205-222 beats per minute; Table 1 ).
One hundred seventeen young athletes participated in competitive sports, and 12 participated in dangerous sports. Basketball and soccer were the most common competitive sports. Other sports included track and field, volleyball, and baseball. There were 79 athletes participating at high school or college varsity or junior varsity levels (Table B in the Data Supplement). Details of the 20 participants playing on college teams (three division 1) are shown in Table 2 . Subjects spent a median of 9 hours per week (IQR, 4-15 h/wk) participating in practice or competition during the relevant season.
Median follow-up was 42 months (IQR, 25-49 months) totaling 4752 person-months (396 person-years) of follow-up. Nine patients did not complete the study, and 11 were lost to follow-up (all confirmed alive). Seven withdrew, 2 developed worsening cardiac or medical conditions that decreased their ability to exercise, and none died.
Primary End Point
There were no tachyarrhythmic deaths or externally resuscitated tachyarrhythmia during or after sport participation and no severe injury resulting from arrhythmia-induced syncope or shock during sports.
Secondary End Point: Shock Episodes and Multiple Shock Episodes
Thirty-five (27%) athletes received at least 1 shock with overall 49 shocks ( Table 3 ). There were 29 appropriate shocks occurring in 18 individuals, of which, 6 appropriate shocks in 4 individuals occurred during competition or practice (Tables 3 and 4 ), a rate of 1.5 appropriate shocks during sports, per hundred person-years. The 4 individuals all were in the highly competitive subgroup. The 4 receiving appropriate shocks during sports reported 17±7.1 hours of competition or practice during their season, 322±166 hours per year, versus 11.5±8.1 and 196±137 in those who received appropriate shocks only at other times, and 10±7.8 and 217±182 in those who did Congenital heart disease 15 (12) Idiopathic VT/VF (normal heart) 10 (7.8) not receive any appropriate shocks. Of the 4 athletes who received appropriate and the 5 who received inappropriate shocks during sports, all were prescribed β-blockers. Two individuals had ventricular arrhythmias requiring multiple shocks for termination, which did not occur during competition or practice-first, a female lacrosse player with catecholaminergic polymorphic ventricular tachycardia who received multiple appropriate shocks after running on her own, and second, a male baseball player with hypertrophic cardiomyopathy, whose ventricular arrhythmia occurred while socializing. There were 5 inappropriate shocks during competition or practice. Freedom from lead malfunction was 92.3% at 5 years and 79.6% at 10 years (Figure) .
One hundred and five athletes stopped participation in all or some sports during the follow-up period: 86 (82%) for nonmedical reasons (graduation from high school or middle school), 7 (6.7%) because of an ICD shock (4 appropriate, 3 inappropriate; 4 sports related), and 1 (1%) because of worsening cardiac condition. Of 7 athletes who stopped because of a shock, 3 stopped all sports, and 4 stopped one sport.
DISCUSSION
The burden of sudden cardiac death in the young is disproportionately larger because of their greater life expectancy and the tragic effect on families and communities. Since 1980, the ICD is proven to be effective in preventing sudden cardiac death in patients of all ages, including children and adolescents, with cardiac disease at high risk of ventricular arrhythmia, [10] [11] [12] and for patients with risk factors, ICDs are more cost-effective for the young recipients because of the greater life expectancy. 13 However, when such young patients are athletic, prior recommendations disqualified patients with ICDs from competitive and high-intensity sports except those with low cardiovascular demand, such as billiard, bowling, or golf.
The potential benefits of physical activity and sports participation for young patients include decreased risk for obesity, metabolic syndrome, coronary and peripheral artery disease, stroke, diabetes mellitus, and other physical disorders.
14 There are additional benefits of exercise including a positive effect on general mental health, decreased risk for depression, and improvement in feelings of wellbeing, all of which improve overall quality of life. 14, 15 Many young patients experi- ence distress and decreased quality-of-life after ICD, often directly related to restriction from sports. 16 All of the youth included in this study benefited from sports participation during the entire length of school, with 82% stopping competition only at graduation. Moreover, 4 of 7 patients who changed sports participation because of an ICD shock gave up only 1 sport; these youth voted with their feet and continued to play other sports, despite the risk-a strong testament to the perceived value of participation for these patients and their families.
In this study, shocks for ventricular arrhythmias occurred during sports, but all were successful at termination of arrhythmia without harm. Indeed, we show that many young athletes with ICDs can participate in competitive and high-intensity sports without failure to terminate arrhythmias or injury, despite the shocks, confirming results of a smaller single-center registry of 21 young people. 10 The rate of appropriate shocks during sports was low-1.5 per hundred person-years, and of the total shocks received, less than one-quarter occurred during sports. This suggests that restriction from this activity would not have a large impact on the overall burden of treated arrhythmias. Only 4 athletes received appropriate ICD shocks during sports, precluding the identification of meaningful and statistically significant predictors of risk. Although hours spent in competition or practice were greater for the 4 athletes who received shocks during sports, there was a wide variation; so whether longer hours spent in competition or practice significantly increase the likelihood of appropriate shock during sports cannot be determined from this study. Although all of the athletes who received shocks, whether appropriate or inappropriate, during sports were prescribed β-blockers, we do not know whether they were taking them at the time. Further research is needed to define other factors that can reduce ICD shocks.
The first report from this prospective, multinational registry, published in 2013, 8 has already influenced consensus recommendations, which are now more lenient describing that competitive sports may be considered for the athlete with an ICD. 4 The present reports will further inform the dialog and shared decision-making concerning sports participation in the important population of young athletes involved in school and college sports. In the shared decision-making model, termed the pinnacle of patient-centered care, 17 the role of the physician and caregivers is to explain the risks and benefits of options and to understand how to reconcile these options with their own values. Shared decision has been used successfully in pediatric populations. 18 A key part of a shared decision-making conversation involves helping patients understand the data and how it may apply to their own situation. Current guidelines encourage regular exercise for all youth because of important physical, social, and emotional long-term benefits, 14 and other guidelines emphasize the need for counseling of athletes with cardiovascular disease who may wish to return to play. 19, 20 The topic of return to play for youth is even more complex than for older patients because of the added interplay between patients and parents, their emotional connections, and often divergent perceived value of sport in life. This report will help physicians bring concrete, objective data to the conversations about return to play for their patients with ICDs.
The population of this study was similar to the general population of children with ICDs with a few exceptions. Compared with 1 large, single pediatric and congenital heart center retrospective review of ICD therapy for patients ages ≤30 years of age, the young patients in this registry had similar clinical characteristics, including 30% meeting strict indication criteria of secondary prevention (resuscitated cardiac arrest) before implantation in both studies. 19 However, in contrast to prior reviews, only 12% of participants in this sports registry had congenital heart disease compared with 42% in 2 prior single-center studies. 21, 22 Most participants in this study had normal ventricular function suggesting a selection bias wherein athletes in our study, who chose to play sports and chose to enroll, were generally healthier than patients with ICDs who do not play sports and who did not enroll, and these data cannot be applied to athletes with decreased ventricular function. Also, there was no control group. Although numbers of appropriate and inappropriate shocks were similar to those in unselected populations, whether these athletes would have had more or fewer arrhythmias had they stopped exercising cannot be determined. An ongoing study, LIVE-HCM/ LQT (Exercise in Genetic Cardiovascular Conditions) is enrolling both active and inactive individuals and may help answer this question. 23 The concept of implanting an ICD in young person primarily to allow competition has been raised. However, ICD implantation carries significant risks especially in youth, 21, 22, 24, 25 and appropriately, the recently updated eligibility recommendations, specifically recommend against implantation for this reason in a patient not otherwise meeting criteria for an ICD. 4 Whether ultimately smaller, subcutaneous devices can be developed that change the risk-benefit ratio in this situation is unknown. More importantly, it is unknown to what extent sports increase risk in patients diagnosed with genetic cardiovascular disease in whom risk assessment does not indicate high risk of arrhythmia. Ongoing studies may shed light on this question. 23 Unfortunately, for this cohort of young athletes, 35% of shocks were inappropriate. Indeed, inappropriate ICD shocks continue to be a problem for young patients regardless of participation in sports. DeWitt et al 19 found 36% of 140 pediatric patients (<21 years of age) experienced inappropriate shocks or other device complications (lead failure, reintervention, atrial lead failure, infection, bleeding, thrombosis, pneumothorax, and generator replacement) during a mean 4-year follow-up. The defined problematic factors include size mismatch, somatic growth, frequent sinus tachycardia or supraventricular tachycardia, and the use of nonstandard hybrid and epicardial approaches for device placement owing to technical issues. 19 It is increasingly recognized that many arrhythmias will terminate spontaneously and that not all appropriate shocks represent aborted sudden death. The importance of programing higher rate cutoffs and longer durations is now demonstrated in older populations 26 in addition to younger populations. 27 Further detailed analysis of this registry may further direct programing for the younger athlete population. In the future, young athletes may benefit from strategies that reduce inappropriate and unnecessary shocks.
In a single-center retrospective study, Garnreiter et al 27 found inappropriate shock rates (shock for any rhythm other than ventricular tachyarrhythmia) in youth in only 9.7% (n=14) of their cohort. Similar to this study and other reports of ICDs in youth, inappropriate shocks were caused by supraventricular tachycardia (n=6), lead malfunction (n=4), sinus tachycardia (n=3), and T-wave oversensing (n=1). 27 Importantly,
Garnreiter et al 26 noted that patients with shocks programed at slower ventricular detection rates were more likely to receive inappropriate shocks from all of these causes. Because there were no instances of syncope or death secondary to untreated ventricular tachycardia or ventricular fibrillation failing to meet programed detection rate or duration, lenient ventricular detection rates had no adverse and only positive effects, including reduction of inappropriate and unnecessary shocks. Of note, 75% of youth in the Garnreiter study were taking β-blockers, and this medication may also have decreased the rate of inappropriate shocks. 27 Although it has been hypothesized that athletic activity might increase lead malfunction, lead malfunction rates in this cohort (20% during 10 years) were similar to those previously reported in the overall study and similar or better than contemporary studies of ICD leads in young patients. 25 A limitation of this study is that shocks were selfreported by young individuals and their parents who may not be as aware of shocks or who purposefully withheld information about shocks to keep playing. Underreporting of shocks would inevitably underestimate true frequency. However, given the age of athletes was <21 years and most were participants in organized sports, it is highly likely that shock events were witnessed by adult observers and the event reported to the athletes, even if the athletes themselves failed to recognize shocks. In addition, although many athletes participated in moderate-contact activities, such as soccer and basketball, few patients participated in aggressive contact sports; so conclusions cannot be drawn about the safety of contact sports like football or rugby from this registry. No athlete in this study had a subcutaneous ICD, and safety of sports for individuals with this device requires further research.
CONCLUSIONS
Young athletes with ICDs may experience shocks during sport and at other times, but no serious adverse outcomes occurred. Shock rates and lead malfunction rates in young athletes were similar to unselected pediatric populations. The decision on return-to-sport participation after an ICD should be individualized and discussed between physician, athlete, and parents.
